/PRNewswire/ The "U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis.
/PRNewswire/ The U.S. solid tumor testing market is projected to reach $18.28 billion in terms of revenue by 2032, at a CAGR of 6.19%, suggests the premium.